Scienture Holdings financials
$0.2666−1.15%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $431.6K | $136.6K |
| Gross profit | $331.5K | $6.0K |
| Gross margin | 76.8% | 4.4% |
| Operating income | -$42.6M | -$14.7M |
| Net income | -$41.5M | $9.1M |
| Net margin | −9618.0% | 6634.7% |
| Diluted EPS | $-2.70 | $2.48 |
| EBITDA | -$13.7M | -$12.9M |
| Operating cash flow | -$13.4M | -$14.3M |
| Free cash flow | -$13.4M | -$14.3M |
| Diluted shares | 15.3M | 3.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $6.7M | $308.1K |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $0.00 | $3.3M |
| Total assets | $84.2M | $104.9M |
| Total liabilities | $14.1M | $25.8M |
| Shareholders' equity | $70.1M | $79.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology